Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1989-10-27
1992-01-28
Wax, Robert A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
436 64, 436813, 424 858, G01N 33574, G01N 3348, A61K 3704
Patent
active
050843800
ABSTRACT:
Monoclonal antibodies reactive with oncogenic and activated ras p21 proteins containing glutamic acid, arginine or valine at position 12 and unreactive with normal ras p21 proteins containing glycine at position 12. The antibodies are secreted by hybridomas obtained by immunizing mice with synthetic dodecapeptides corresponding in amino acid sequence to positions 5-16 of normal ras p21 proteins, except having glutamic acid, arginine or valine in place of glycine at position 12. The antibodies and Fab fragments thereof are useful for diagnosis, staging and classification of malignant and premalignant lesions.
REFERENCES:
patent: 4535058 (1985-08-01), Weinberg et al.
patent: 4568640 (1986-02-01), Rubin
patent: 4699877 (1987-10-01), Cline et al.
patent: 4725550 (1988-02-01), Perucho et al.
patent: 4762706 (1988-08-01), McCormick et al.
patent: 4786718 (1988-11-01), Weinberg et al.
patent: 4820631 (1989-04-01), Lacal et al.
patent: 4898932 (1990-02-01), Carney
Jansson et al., Cancer, pp. 1329-1337, vol. 65 (3/15/90).
Nq et al., "Plasma Detection of Activated Ras p21 Expression in MMTV/VHA RAS Transgenic Mice" Abstract.
Carney et al., "Detection of Activated Ras Proteins in the Plasma of Tumor Bearing Mice" Abstract.
Hamer et al., "Quantitation of HER-2/Neu Proteins in Breast and Ovarian Carcinomas" Abstract.
Brandt-Rauf et al., Br. J. Industrial Medicine, 45:689-693 (1988).
Andreeff et al., Blood, pp. 676-681, vol. 67, No. 3 (Mar. 1986).
Barch et al., Cell. Biol., Abst. #591, St. Louis, Mo. (1987).
Bizub et al., Orcogene, pp. 131-142, vol. 1 (1987).
Bos et al., Nature, pp. 726-730, vol. 315 (Jun. 27, 1985).
Bos et al., Cancer Res., pp. 4682-4689, vol. 49 (Sep. 1, 1989).
Carney et al., 78th Ann. Mtg. Amer. Assn. for Cancer Res., May 20-23, 1987.
Carney et al., UCLA Symposia, Jan. 20-Feb. 15, 1986, Steamboat Springs, Colo., NY J. Cell. Bio., Suppl. 10A (1986).
Carney et al., Fifth Ann. Cong. for Hybridoma Res., Jan. 26-29, 1986, Baltimore, Md.
Carney et al., Lab. Invest. 54:10A, Jan. 1986.
Carney et al., 8th Intl. Cong. of Histochemistry & Cytochemistry, Aug. 1988.
Carney et al., Lab. Invest. 58 (1988).
Carney et al., J. Cell. Bio., pp. 207-214, vol. 32 (1986).
Carney et al., Intl. Acad. Pathol., Mar. 1987.
Carney et al., Third Ann. Mtg. on Oncegenes, 1987.
Carney et al., Amer. Assn. Clin. Chem., New Orleans, La., Jul. 24-28, 1988.
Carney et al., Monoclonal Antibodies & Cancer Therapy, pp. 565-572, 1985.
Carney et al., UCLA Symposium Series, Apr. 17-30, 1988, Keystone, Colo.
Carney et al., Human Tumor Antigens & Specific Tumor Therapy, pp. 53-62 (1989).
Carney et al., 69th Ann. Mtg. FASEB (Apr. 1985).
Carney et al., Cold Spring Harbor Lab. Mtg., Sep. 1988.
Carney et al., Apr. 1986 Mtg. FASEB.
Carney et al., PNAS USA, pp. 7485-7489, vol. 83 (Oct. 1986).
Carney et al., UCLA Symp. Mol. Cell. Biol., New Ser., pp. 565-572, vol. 27 (1985), CA, vol. 104 (1986), No. 166570B.
Carney et al., 20th Ann. OakRidge Conf. on Advanced Anal. Concepts for Clin. Labs. (Apr. 1988).
Carney et al., DuPont's Biotechnology Update, p. 16 (Apr. 1988).
Caruso et al., Int. J. Cancer, pp. 587-595, vol. 38 (1986).
Chang et al., Nature, pp. 479.483, vol. 297 (Jun. 10, 1982).
Clanton et al., Mol. Cell. Biol., pp. 3092-3097, vol. 7, No. 9 (1987).
Clark et al., PNAS USA, pp. 5280-5284, vol. 18, No. 16 (Aug. 1985).
Cooper et al., Biochimica et Biophys. Acta, pp. 9-20, vol. 738 (1984).
DeLellis et al., Intl. Acad. Pathol., Mar. 1987.
Der et al., Cell, pp. 167-176, vol. 44 (Jan. 17, 1986).
Fasano et al., J. Mol. Appl. Genet., 2(2):173-180 (1983).
Feramisco et al., Nature (England), 314(6012):639-642 (Apr. 18-24, 1985).
Finkel et al., Cell, pp. 151-158, vol. 37 (May 1984).
Freedman et al., In Vitro Cellular Devel. Biol., pp. 621-624, vol. 22, No. 10 (Oct. 1986).
Furth et al., J. of Virol., pp. 294-304, vol. 43, No. 1 (Jul. 1982).
Gallick et al., PNAS, pp. 1795-1799, vol. 82 (Mar. 1985).
Gambke et al., Nature, pp. 476-478, vol. 307 (Feb. 2, 1984).
Ghosh et al., J. Clin. Pathol. (England), pp. 428-434, vol. 39, No. 4 (Apr. 1986).
Gibbs et al., PNAS (USA), pp. 5704-5708, vol. 81 (Sep. 1984).
Hamer et al., CA106:174296y, p. 550, vol. 106 (1987).
Hamer et al., 72nd Ann. Mtg. FASEB, May 1-5, 1988, Las Vegas, Nev.
Hamer et al., Amer. Commer. & Indus. Conf. & Expo. in Biotech., Apr. 27-May 1, 1986, Boston, Ma.
Hand et al., Biochem. Biophys. Acta., 908(2):131-142, (1987).
Hand et al., JNCI, 79(1):59-66, (1987).
Hand et al., PNAS, pp. 5227-5231, vol. 81, (Aug. 1984
Herlyn, J. Clin. Immunol., pp. 135-140, vol. 2, No. 2, (1982).
Hirai et al., Nature, pp. 430-432, vol. 327, (Jun. 4, 1987).
Ho et al., FASEB, vol. 46(3), 1987.
Kuzrock et al., Cancer Res., pp. 1530-1534, vol. 46, (Mar. 1986).
Lacal et al., Mol. & Cell. Biol., pp. 1002-1009, vol. 6, No. 4, (Apr. 1986).
Lee et al., Int'l Acad. Pathol., Mar. 1987.
Lefebvre et al., Lab. Invest., 54:35a, Jan. 1986.
Liu et al., Nature, pp. 186-188, vol. 330, (Nov. 12, 1987).
Manne et al., PNAS (USA), pp. 376-380, vol. 82, (Jan. 1985).
McGrath et al., Nature, pp. 644-649, vol. 310, (Aug. 1984).
Metzgar et al., Cancer Res., pp. 601-608, vol. 42, (Feb. 1982).
Moore et al., Nature, pp. 733-734, vol. 327, (Jun. 25, 1987).
Ng et al., 4th Ann. Oncogene Mtg., Frederick, Md., Jul. 1988.
Niman et al., Clin. Lab. Med. (US), 6(1):181-196, (Mar. 1986).
Niman et al., PNAS (USA), pp. 7924-7928, vol. 82, (Dec. 1985).
Nishida et al., Biochem. Biophys. Res. Common., 146(1):247-252, (1987).
Nitta et al., Jpn. J. Cancer Res. (Gann), pp. 21-26, vol. 78, (Jan. 1987).
Ohuchi et al., Can. Res., 47(5):1413-1420, (1987).
Ohuchi et al., Can. Res., pp. 2511-2519, vol. 46, (May 1986).
Papageorge et al., J. Virol., pp. 509-519, vol. 44, No. 2, (Nov. 1982).
Parada et al., Nature, pp. 474-476, vol. 297, (Jun. 10, 1982).
Poe et al., J. Biol. Chem., pp. 3906-3909, vol. 260, No. 7, (Apr. 10, 1985).
Pullano et al., 4th Ann. Oncogene Mtg., Frederick, Md., Jul. 1988.
Pullano et al., 72nd Ann. Mtg., FASEB, Las Vegas, Nev., May 1-5, 1988.
Rabin et al., Cold Spring Harbor Lab. Mtg., Sep. 1988.
Radosevich et al., Amer. Fed. Clin. Res., Chicago, Ill., Sep. 1987.
Reddy et al., Nature, pp. 149-152, vol. 300, (Nov. 11, 1982).
Robinson et al., Br. J. Cancer, pp. 877-883, vol. 54, (1986).
Santos et al., Science, pp. 661-664, vol. 223, (Feb. 17, 1984).
Santos et al., Nature, pp. 343-344, vol. 298, (Jul. 22, 1982).
Schlom, 5th Ann. Cong. Hybridoma Res., pp. 165-166, Baltimore, Md., Jan. 26-29, 1986.
Scolnick et al., PNAS (USA), pp. 5355-5359, vol. 76, (Oct. 1979).
Sevier et al., Clin. Chem., pp. 1797-1806, vol. 27, No. 11 (1981).
Shilo et al., Nature, pp. 607-609, vol. 289 (Feb. 12, 1981).
Shimizu et al., Nature, 304 (5926), pp. 497-500 (1983), Cited in Chem. Absts. 99(19):153093b.
Srivastava et al., Mol. Cell. Biol., pp. 3316-3319, vol. 5, No. 22, Nov. 1985.
Sukumar et al., Science, pp. 524-526, vol. 240 (Apr. 22, 1988).
Sweet et al., Nature, pp. 273-275, vol. 311 (Sep. 1984).
Tabin et al., Nature, pp. 143-149, vol. 300 (Nov. 11, 1982).
Tahara et al., Jpn. J. Cancer Res. (Gann), pp. 517-522 (1986).
Tanaka et al., Can. Res., pp. 1465-1470, vol. 46 (Mar. 1986).
Tanaka et al., PNAS (USA), pp. 3400-3404, vol. 82 (May 1985).
Taparowsky et al., Cell, pp. 581-586, vol. 34 (1983).
Taparowsky et al., Banbary Rpt., 14:123-133 (1983), Cited in Chem. Abst., CA100(1):1425n.
Thor et al., Nature, pp. 562-565, vol. 311 (Oct. 11, 1984).
Trimpe et al., 3rd Ann. Mtg. on Oncogenes (1987).
Trimpe et al., Intl. Acad. Pathol., U.S. & Can. Div., Feb. 29-Mar. 3, 1988, Washington, DC.
Trimpe et al., 11th Ann. San Antonio Breast Cancer Symp., Nov. 29-30, 1988.
Trimpe et al., Cold Spring Harbor Lab. Mfg., Sep. 1988.
Trimpe et al., Amer. Assn. Can. Res., New Orleans, LA, May 24-28, 1988, #5960.
Wodnar-Filipowicz et al., Oncogene, pp. 457-461, vol. 1, No. 4 (1987).
Wolfe et al., Lab. Invest., 52:77a (1985).
Wong et al., Can. Res., pp. 6029-6033, vol. 46 (Dec. 1986).
Yuasa et al., Nature, pp. 775-779, vol. 303 (Jun. 30, 1983).
Zarbl et al., Nature, pp. 382-385, vol. 315 (May 30, 1985).
Applied bioTechnology
Bronstein Sewall P.
Eisenstein Ronald I.
Wax Robert A.
Woodward M. P.
LandOfFree
Monoclonal antibodies reactive with activated and oncogenic ras does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies reactive with activated and oncogenic ras , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies reactive with activated and oncogenic ras will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1860660